These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 929380)

  • 1. [Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus].
    Rass IT; Borisov IA; Nikishova TA; Sura VV
    Ter Arkh; 1977; 49(8):110-5. PubMed ID: 929380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of the indicators of hemostasis during corticosteroid treatment of systemic lupus erythematosus].
    Iakumova NIa; Ivanova AV; Sukhanov AA
    Vopr Revm; 1975; (1):63-5. PubMed ID: 1121805
    [No Abstract]   [Full Text] [Related]  

  • 3. [Change in the amino acid spectrum of the blood serum in patients with lupus erythematosus under the effect of therapy].
    Pavlova LT
    Vestn Dermatol Venerol; 1970 Jul; 44(7):11-4. PubMed ID: 5511088
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tyrosine metabolism in systemic lupus erythematosus and therapeutic use of corticosteroid hormones. Preliminary report].
    Rass IT; Sura VV
    Ter Arkh; 1974; 46(9):135-40. PubMed ID: 4439299
    [No Abstract]   [Full Text] [Related]  

  • 5. [Presocyl in the treatment of lupus erythematosus].
    Glavinskaia TA; Zernov VP; Ostroumova TN
    Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
    [No Abstract]   [Full Text] [Related]  

  • 6. [Systemic erythematosus--the blood].
    Yamaguchi H
    Nihon Rinsho; 1968 Dec; 26(12):3426-9. PubMed ID: 5753024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Discontinuous corticosteroid treatment of systemic lupus erythematosus].
    Tareeva IE
    Klin Med (Mosk); 1972 Jun; 50(6):95-9. PubMed ID: 5086287
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
    Itoh H; Fujihira T; Harada S; Kido M; Kajiki A; Nakashima Y; Kuroiwa A
    Kekkaku; 1984 Apr; 59(4):303-8. PubMed ID: 6748459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Objective evaluation of remote results of treatment of systemic lupus erythematosus].
    Ivanova MM; Nasonova VA; Folomeeva OM; Speranskiĭ AI; Kozlova VN
    Ter Arkh; 1977; 49(9):60-6. PubMed ID: 929421
    [No Abstract]   [Full Text] [Related]  

  • 10. Fulminant pneumonitis developed during the middle-dose corticosteroid therapy in systemic lupus erythematosus.
    Oku H; Okamura M; Amatsu K; Ohe A; Kato N; Kanayama Y; Horiguchi T; Inoue T
    Osaka City Med J; 1980; 26(2):145-9. PubMed ID: 7290651
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone mineral density in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S; Deesomchoke U; Lertmaharit S; Uaratanawong S
    J Rheumatol; 2003 Nov; 30(11):2365-8. PubMed ID: 14677178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modification of systemic lupus erythematosus in connection with steroid hormone therapy (clinico-morphological parallels)].
    Vinogradova OM; Potekseva MA
    Sov Med; 1966 Aug; 29(8):25-33. PubMed ID: 5991389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the preparation essentiale in the therapy of lupus erythematosus].
    Glavinskaia TA; Novikov AI; Pavlova LT
    Vestn Dermatol Venerol; 1983 May; (5):4-7. PubMed ID: 6880388
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood tyrosine level in glucocorticoid therapy].
    Rass IT
    Lab Delo; 1981; (8):485-8. PubMed ID: 6168808
    [No Abstract]   [Full Text] [Related]  

  • 16. Release of leukotriene C4 from human monocytes: defects in patients with systemic lupus erythematosus.
    Yamane K; Matsumura T; Suzuki H; Kono I; Kashiwagi H
    Arerugi; 1988 May; 37(5):301-8. PubMed ID: 3140768
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
    Oshimi K; Gonda N; Sumiya M; Kano S
    Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus.
    Kanayama Y; Shiota K; Horiguchi T; Kato N; Ohe A; Inoue T
    Arch Intern Med; 1981 Aug; 141(9):1176-9. PubMed ID: 7259378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus.
    Nakayamada S; Saito K; Nakano K; Tanaka Y
    Arthritis Rheum; 2007 May; 56(5):1559-68. PubMed ID: 17469136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of peripheral blood lymphocytes from systemic lupus erythematosus patients on human bone marrow granulocyte precursor cells (colony-forming units in culture).
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Stem Cells (1981); 1982; 2(3):164-76. PubMed ID: 7163917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.